Omid Hamid, MD of the Angeles Clinic discusses the phase III NEMO trial and the novel MEK inhibitor Binimetinib
Phase III NEMO trial and the novel MEK inhibitor Binimetinib
Omid Hamid, MD of the Angeles Clinic discusses the phase III NEMO trial and the novel MEK inhibitor Binimetinib